Cargando…
Synergistic effect of meta-tetra(hydroxyphenyl)chlorin-based photodynamic therapy followed by cisplatin on malignant Hep-2 cells
PURPOSE: Tumor drug resistance limits the response to chemotherapy. Interestingly, sequential combination therapy enhances the anticancer efficacy of drugs like cisplatin (CDDP) via synergistic effects. We assayed the synergistic effects of combined photodynamic therapy programmed death receptor-lig...
Autores principales: | Xue, Kai, Wang, Yi-Nan, Zhao, Xue, Zhang, Hong-Xin, Yu, Dan, Jin, Chun-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636612/ https://www.ncbi.nlm.nih.gov/pubmed/31371990 http://dx.doi.org/10.2147/OTT.S198422 |
Ejemplares similares
-
Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
por: Andrejevic-Blant, S., et al.
Publicado: (1997) -
Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats.
por: Alian, W., et al.
Publicado: (1994) -
Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model
por: Rovers, J P, et al.
Publicado: (1999) -
Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.
por: Ris, H. B., et al.
Publicado: (1991) -
The microneedles carrying cisplatin and IR820 to perform synergistic chemo-photodynamic therapy against breast cancer
por: Fu, Ji-jun, et al.
Publicado: (2020)